Skip to content
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
IFPMA
  • Who We Are
    • IFPMA in Brief
    • Our Governance and Leadership
    • Our Membership
      • Full Members
        • Associations
        • Companies
      • Affiliate Members
    • Our Experts
    • Join Us
  • Topics
  • News Center
    • News Releases
    • Blog
      • Global Health Matters
      • Science Matters
      • DG’s Column
    • Statements
  • Resources
    • Publications
      • News Releases
      • Statements
      • Position Papers
      • Publications
      • External Studies
      • Infographics
      • Event Highlights
    • Multimedia
      • Interviews
      • Videos
      • Slides
    • IFPMA Interactive Platforms
      • IFPMA COVID-19 Hub
      • Global Health Progress
      • 50 Years of Global Health Progress
  • Events
    • Upcoming IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
    • Past IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
  • Partners
  • BCR
  • Inventing Medicines and Vaccines
  • Strengthening Regulatory Systems
  • Ethics and Business Integrity
  • Boosting Innovation and Access
  • Tackling Global health challenges
Climate change Economic footprint IP Sustainable innovation Value of innovation

spotlight

Value of innovation

Inventing Medicines and Vaccines
African Medicines Agency Biosimilars Biotherapeutic medicines Falsified medicines Import testing Pharmacovigilance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain The Africa Regulatory Network (ARN) The ARN: Le réseau africain de réglementation pharmaceutique

spotlight

Pharmacovigilance

Strengthening Regulatory Systems
IFPMA Code of Practice (2019) Our Ethos in Action Our Ethos Code eLearning Tool IFPMA Notes for Guidance IFPMA Complaint Operating Procedure How to File a Code Complaint Complaint Submission Form Cases Business Ethics for APEC SMEs Initiative Consensus Framework for Ethical Collaboration

spotlight

IFPMA Code of Practice (2019)

Ethics and Business Integrity
Access to medicines Global Policy Principles on Digital Health Health technology assessment IP Technology Transfer Trade

spotlight

Access to medicines

Boosting Innovation and Access
Ageing Antimicrobial resistance Cancer Child and maternal health COVID-19 Diabetes Ebola Falsified medicines HIV/AIDS Influenza Malaria Mental and neurological disorders Neglected tropical diseases Non-communicable diseases Pandemic Preparedness Public health implications of the implementation of the Nagoya Protocol Rare diseases Supply chain Sustainable development goals Tuberculosis Universal Health Coverage Vaccination confidence Vaccines innovation Vaccines protect communities Vaccines sustainability Value of immunization Viral hepatitis

spotlight

Universal Health Coverage

Tackling Global health challenges
  • Home
  • >
  • Resources
  • >
  • Publications
  • >
  • AMR Industry Alliance 2020 progress report

AMR Industry Alliance 2020 progress report

Published on: 16 January 2020

Downloads

» AMR-2020-Progress-Report
» Press-release-AMR-Industry-Alliance-Report-2020-til-16-Jan-2020

Resources

AMR life science industry 2020 report: Successes and setbacks in fighting superbugs
News Releases

News Releases

AMR life science industry 2020 report: Successes and setbacks in fighting superbugs

AMR Industry Alliance Progress Report: Tracking Progress to Address AMR
External Studies

External Studies

AMR Industry Alliance Progress Report: Tracking Progress to Address AMR

AMR Industry Alliance Statement – Global call for action on drug-resistant infections, 12-13 October 2017, Berlin (Conference organized by Wellcome Trust)
Statements

Statements

AMR Industry Alliance Statement – Global call for action on drug-resistant infections, 12-13 October 2017, Berlin (Conference organized by Wellcome Trust)

AMR Position Papers
Position Papers

Position Papers

AMR Position Papers

Global Biopharmaceutical Industry Takes Action to Combat Antimicrobial Resistance (AMR)
News Releases

News Releases

Global Biopharmaceutical Industry Takes Action to Combat Antimicrobial Resistance (AMR)

The R&D-based biopharmaceutical industry at the forefront of addressing AMR
Infographics

Infographics

The R&D-based biopharmaceutical industry at the forefront of addressing AMR

Related Blog Entries

Underuse of antibiotics could be a bigger problem than overuse

Underuse of antibiotics could be a bigger problem than overuse

Antimicrobial resistance: A ticking time bomb

Antimicrobial resistance: A ticking time bomb

Progress in discovering new antibiotics is imperative

Progress in discovering new antibiotics is imperative

Related Links

AMR Industry Alliance Website
IFPMA Partners - AMR Industry Alliance

Related Topics

Antimicrobial resistance

Tags

  • AMR
  • antibiotic resistance
  • Antibiotics
  • Drug-resistant Infections
IFPMA

Chemin des Mines 9
1202 Geneva
Switzerland

+41 22 338 32 00
info@ifpma.org

  • File a Code Complaint
  • Privacy Policy
  • Terms of Use
  • Access to Our Extranet
  • Careers
  • Contact Us
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
Designed and Produced by ACW
^ Back to Top